Browsing by Author "Prostran, Milan (7004009033)"

Now showing 1 - 2 of 2

Some of the metrics are blocked by your
consent settings
Morphological differences among cavum septi pellucidi obtained in patients with schizophrenia and healthy individuals: Forensic implications. A post-mortem study
(2005)
Filipović, Branislav (56207614900)
;
Kovačević, Slobodan (7006413964)
;
Stojičić, Milan (24554259500)
;
Prostran, Milan (7004009033)
;
Filipović, Branka (22934489100)
Cavum septi pellucidi (CSP), especially when longer than 6 mm, has been recognized as a neurodevelopmental anomaly associated with schizophrenia. The present post-mortem study was designed to determine the importance of linear parameters of CSP and to evaluate the possible differences of CSP in schizophrenic patients (n = 25 out of 110 CSP+ brains) and normal persons (n = 40 out of 110 CSP+ brains). According to our results, schizophrenia patients had significantly longer and wider CSP than normal individuals. Also, statistical analysis revealed a higher suicide rate in CSP-positive patients with schizophrenia.
Some of the metrics are blocked by your
consent settings
Morphological differences among cavum septi pellucidi obtained in patients with schizophrenia and healthy individuals: Forensic implications. A post-mortem study
(2005)
Filipović, Branislav (56207614900)
;
Kovačević, Slobodan (7006413964)
;
Stojičić, Milan (24554259500)
;
Prostran, Milan (7004009033)
;
Filipović, Branka (22934489100)
Cavum septi pellucidi (CSP), especially when longer than 6 mm, has been recognized as a neurodevelopmental anomaly associated with schizophrenia. The present post-mortem study was designed to determine the importance of linear parameters of CSP and to evaluate the possible differences of CSP in schizophrenic patients (n = 25 out of 110 CSP+ brains) and normal persons (n = 40 out of 110 CSP+ brains). According to our results, schizophrenia patients had significantly longer and wider CSP than normal individuals. Also, statistical analysis revealed a higher suicide rate in CSP-positive patients with schizophrenia.